Talk:Metformin: Difference between revisions
Jump to navigation
Jump to search
imported>Howard C. Berkowitz (New page: {{subpages}}) |
imported>Howard C. Berkowitz |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
==Adverse effects?== | |||
I think the statement "Metformin can also exhibit renal toxicity; it may increase the risk of cardiovascular events, although this needs to be traded against the cardiovascular risks of uncontrolled glucose." needs a citation to support it and its possible magnitude. - [[User:Robert Badgett|Robert Badgett]] 14:52, 18 March 2010 (UTC) | |||
*A citation, more available <ref>{{citation | |||
| url = https://secure.muhealth.org/~ed/students/articles/AnnEM_38_p0068.pdf | |||
| title =Oral Agents for the Treatment of Type 2 Diabetes Mellitus: Pharmacology, Toxicity, and Treatment | |||
| journal = Annals of Emergency Medicine | |||
| author = Harrigan, RA; Nathan,MS; Beattie, P | |||
| date = July 2001}}</ref> | |||
==References== | |||
{{reflist}} | |||
Latest revision as of 09:17, 19 March 2010
Adverse effects?
I think the statement "Metformin can also exhibit renal toxicity; it may increase the risk of cardiovascular events, although this needs to be traded against the cardiovascular risks of uncontrolled glucose." needs a citation to support it and its possible magnitude. - Robert Badgett 14:52, 18 March 2010 (UTC)
- A citation, more available [1]
References
- ↑ Harrigan, RA; Nathan,MS; Beattie, P (July 2001), "Oral Agents for the Treatment of Type 2 Diabetes Mellitus: Pharmacology, Toxicity, and Treatment", Annals of Emergency Medicine